Emmaus Life Sciences Announces Submission of Marketing Authorization Application to the Saudi Food and Drug Authority

Source :: GlobeNewswire. August 18, 2020
Publication Year :: 2020
Abstract: TORRANCE, Calif., Aug 18, 2020 (GLOBE NEWSWIRE via COMTEX) -- Emmaus Life Sciences, Inc. (OTCPK: EMMA), a leader in sickle cell disease treatment, announced today the submission of an application [...]

Subjects :: Glutamine
Marketing
Drug approval
Sickle cell anemia -- Drug therapy
Banking, finance and accounting industries
Business
Endari (Medication)

Tools